CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 1, 2026 · Phase 3 readout

BMY Phase 3 readout: a neutral outcome, +0.0%

On November 1, 2026, KarXT — Bristol-Myers Squibb Company (Bipolar-I Disorder With Mania or Mania With Mixed Features) reached its Phase 3 readout. The result was a neutral outcome, and the stock moved +0.0% in the window around the event.

The move

$62.48
1d before
$62.48
Event day
$63.02
1d after
$62.14
5d after

Pre-catalyst setup

+0.4%
30-day run-up
3608%
30-day volatility
1.0×
volume spike